# Report: 3_NPC_neuronal_like_2 (run_1.md)

**Cell type:** Glioblastoma cells (malignant glioma cells)
**Disease:** Glioblastoma multiforme (GBM)
**Tissue:** brain

## Program Summaries
### Extracellular Matrix Remodeling and Invasion
Coordinated secretion and degradation of extracellular matrix components to facilitate glioblastoma cell invasion through brain tissue. This program includes collagen synthesis and deposition (COL3A1, COL6A3), matrix metalloproteinase activity (ADAMTS3, PRSS12), ECM-binding proteins (SMOC2, POSTN, TGFBI), and regulatory proteins (GREM2, VWC2L). In GBM, this program promotes escape from the tumor core and infiltration into surrounding brain parenchyma, supporting mesenchymal transition and treatment-resistant phenotypes.

**Predicted impacts:**
- Enhanced invasive migration into infiltrated brain tissue
- Acquisition of mesenchymal gene expression signature
- Increased mechanical stiffness of local microenvironment
- Reduced chemotherapy penetration through ECM barrier
- Promotion of bevacizumab-resistant phenotype

**Supporting genes:** COL3A1, COL6A3, ADAMTS3, PRSS12, SMOC2, POSTN, TGFBI, GREM2, VWC2L, SERPINI1, PAPPA2, EDIL3, RASGEF1B, FGD4

**References:** [55], [57], [59], [60], [9]

**Biological processes:**
- Collagen secretion and deposition: COL3A1, COL6A3, PAPPA2
- Matrix metalloproteinase activity: ADAMTS3, PRSS12, SERPINI1
- ECM-associated protein binding: SMOC2, POSTN, TGFBI, VWC2L
- Invasion-promoting signaling: GREM2, RASGEF1B, FGD4

**Cellular components:**
- Extracellular matrix structure: COL3A1, COL6A3, SMOC2, POSTN, EDIL3

**Reference notes:**
- Core evidence: GBM cells secrete extensive ECM, particularly collagen VI, which facilitates invasion and is associated with bevacizumab resistance
- ADAM/ADAMTS proteases regulate tissue remodeling through ECM degradation and cell migration
- LIN28B/TGF-β feedback loop promotes TGFBI expression and cancer cell migration
- SMOC proteins regulate cell adhesion, tissue fibrosis, and calcification relevant to tumor microenvironment
- TGFBI is a prognostic marker affecting cancer cell migration and invasion

### Cell Adhesion and Synaptic-Like Junctions
Classical and non-classical cell adhesion molecules that mediate cell-cell contacts and establish specialized junction zones. This program includes classical cadherins (CDH4, CDH9, CDH13, CDH18), contactin-associated proteins (CNTNAP4, CNTN5), and adhesion receptors (LRFN5, TENM2, EFNA5). In GBM, dysregulation of these molecules contributes to loss of normal cell polarity, altered migration dynamics, and altered response to developmental cues that normally restrict proliferation.

**Predicted impacts:**
- Altered cell-cell contact dynamics affecting proliferation control
- Loss of normal neuronal polarity cues
- Enhanced migratory behavior through reduced adhesive restraint
- Increased cellular plasticity and phenotypic switching
- Dysregulated response to developmental guidance molecules

**Supporting genes:** CDH4, CDH9, CDH13, CDH18, CNTNAP4, CNTN5, LRFN5, TENM2, EFNA5, GFRA1

**References:** [11], [27], [30], [33], [37], [8]

**Biological processes:**
- Homotypic cell-cell adhesion: CDH4, CDH9, CDH13, CDH18
- Adherens junction assembly: CDH4, CDH9, CDH13, CDH18, LRFN5
- Trans-synaptic adhesion complex formation: TENM2, CNTNAP4, CNTN5, LRFN5, GFRA1
- Axon guidance and fasciculation: CDH4, CDH9, EFNA5, SEMA3C

**Cellular components:**
- Adherens junction protein complex: CDH4, CDH9, CDH13, CDH18, LRFN5
- Contact zones between epithelial/neural cells: CDH4, CDH9, CDH13, CDH18, CNTNAP4, CNTN5

**Reference notes:**
- Cadherins and nectins cooperate in adhesion and regulate neuronal migration and differentiation
- Classic cadherins show restricted expression patterns in neural tissues during development
- CAMs regulate axon growth, fasciculation, and synaptic specificity through trans-interactions
- Latrophilin-teneurin complexes regulate neuronal circuit assembly
- CNTNAP4 is involved in dopaminergic neuron function and synaptic transmission
- GDNF-GFRα1 complexes support synaptic cell adhesion

### Growth Factor Receptor Signaling
Receptor tyrosine kinases and associated signaling molecules that drive proliferation, survival, and differentiation in GBM. This program includes FGFR2 (fibroblast growth factor receptor), KIT (stem cell growth factor receptor), GFRA1 (GDNF family receptor alpha-1), and downstream signaling mediators. GBM frequently exhibits aberrant RTK signaling which activates Ras/MAPK and PI3K/AKT/mTOR pathways, driving rapid proliferation and therapy resistance.

**Predicted impacts:**
- Enhanced proliferation through Ras/MAPK and PI3K/AKT signaling
- Increased survival signaling and resistance to apoptosis
- Promotion of stemness and self-renewal in cancer stem cells
- Enhanced migration and invasion capabilities
- Reduced responsiveness to differentiation cues

**Supporting genes:** FGFR2, KIT, GFRA1, RASGEF1B, FGD4

**References:** [19], [22], [26], [29]

**Biological processes:**
- Fibroblast growth factor receptor signaling: FGFR2, RASGEF1B, FGD4
- Receptor tyrosine kinase transactivation: KIT, GFRA1, FGFR2, RASGEF1B
- GDNF-GFRα signaling axis: GFRA1

**Cellular components:**
- Receptor tyrosine kinase complexes: FGFR2, KIT, GFRA1

**Reference notes:**
- RTK signaling is among the most frequent molecular alterations in GBM
- PI3K/AKT and Ras/MAPK pathways are major drivers of GBM progression
- FGFR1 is a key regulator of tumor growth, invasion, and cancer stemness in GBM
- FGFR dysregulation in glioma and therapeutic targeting opportunities

### Ion Channel-Mediated Cellular Signaling
Voltage-gated and ligand-gated ion channels that regulate intracellular calcium, potassium, and chloride dynamics. This program includes NMDA receptors (GRIN2A), GABA receptors (GABBR2, GLRA2), ion channels (TRPM3, TRPC5, KCNC2, KCNJ6), and calcium-dependent enzymes (PDE1A, PDE1C). In GBM, ion channel activity regulates cell proliferation, migration, survival, and response to chemotherapy through calcium signaling and electrical properties.

**Predicted impacts:**
- Altered intracellular calcium dynamics affecting proliferation
- Modified excitability and electrical properties of GBM cells
- Dysregulated response to neurotransmitter signals
- Enhanced or reduced drug sensitivity depending on channel status
- Altered cell-cell communication through gap junctions and synaptic-like contacts

**Supporting genes:** GRIN2A, TRPM3, TRPC5, KCNC2, KCNJ6, DPP10, GABBR2, GLRA2, PDE1A, PDE1C, SYT1, SYNPR, RPH3A, SLC17A6, ANO4, CPNE4

**References:** [4], [43], [44], [47]

**Biological processes:**
- NMDA receptor-mediated glutamate signaling: GRIN2A
- TRPM ion channel regulation of proliferation: TRPM3, TRPC5
- GABAergic and glycinergic inhibitory signaling: GABBR2, GLRA2, CNTNAP4
- Potassium channel regulation of excitability: KCNC2, KCNJ6, DPP10
- Calcium-dependent phosphodiesterase signaling: PDE1A, PDE1C, CPNE4

**Cellular components:**
- Ion channel protein complexes: TRPM3, TRPC5, KCNC2, KCNJ6, ANO4
- Synaptic vesicle release machinery: SYT1, SYNPR, RPH3A, SLC17A6

**Reference notes:**
- TRPM3 loss of expression is a poor prognosis marker in GBM; dysregulation closely related to glioma occurrence and development
- Synaptotagmin is critical calcium sensor for neurotransmitter release; its expression affects exocytosis
- TMEM16 proteins link Ca2+ signals with cellular electrical activity and are dysregulated in cancer
- Anoctamins (TMEM16) in brain cancer: calcium-activated chloride channels in EGFR signaling and glioma

### Axon Guidance and Repulsive Signaling
Molecules mediating repulsive and attractive axon guidance cues that direct neuronal migration and process outgrowth. This program includes semaphorins (SEMA3C), ephrin ligands (EFNA5), netrin receptors (UNC5C, UNC5D), and associated signaling molecules (LINGO2, NDNF). In GBM, aberrant expression of guidance molecules contributes to altered cell migration patterns, invasion into surrounding brain tissue, and escape from normal developmental constraints.

**Predicted impacts:**
- Altered migration direction and invasive behavior
- Loss of normal developmental constraints on cell movement
- Escape from peri-tumoral zones and infiltration into normal brain
- Reprogramming of guidance molecule responses
- Dysregulation of growth cone dynamics

**Supporting genes:** SEMA3C, EFNA5, UNC5C, UNC5D, LINGO2, NDNF, FGD4, RASGEF1B, CPNE4

**References:** [31], [32], [34], [35]

**Biological processes:**
- Semaphorin-mediated repulsion: SEMA3C, LINGO2
- Ephrin-Eph signaling in cell guidance: EFNA5
- Netrin-UNC5 repulsive signaling: UNC5C, UNC5D
- Growth cone collapse and actin dynamics: SEMA3C, FGD4, RASGEF1B

**Cellular components:**
- Neuropilin-plexin receptor complexes: SEMA3C
- Growth cone cytoskeleton: SEMA3C, FGD4, RASGEF1B, CPNE4

**Reference notes:**
- Semaphorins and their receptors mediate axon guidance, cell migration, and growth cone collapse
- UNC5-netrin interactions mediate cell migration and axon guidance through heparin-binding mechanisms
- Semaphorins have multiple roles in axon guidance, cell migration, and cell death with temporal regulation
- Netrin and UNC5 signaling regulates migration of specific neuronal populations during development

### RNA Binding and Post-transcriptional Regulation
RNA binding proteins and regulatory mechanisms controlling mRNA stability, localization, and translation. This program includes RBFOX1 (regulates alternative splicing), LIN28B (suppresses let-7 miRNAs and promotes oncogene translation), and SRRM4 (serine/arginine repetitive matrix protein). In GBM, dysregulation of these RNA binding programs drives stemness, proliferation, metabolic reprogramming, and therapy resistance through altered gene expression.

**Predicted impacts:**
- Altered splicing of genes encoding adhesion and cytoskeletal proteins
- Derepression of multiple oncogenes through let-7 suppression
- Enhanced de novo lipid synthesis supporting rapid proliferation
- Activation of TGF-β signaling and mesenchymal phenotype
- Increased metabolic flexibility and therapy resistance

**Supporting genes:** LIN28B, RBFOX1, SRRM4

**References:** [14], [17], [51], [54], [57]

**Biological processes:**
- Alternative splicing regulation: RBFOX1, SRRM4
- Let-7 microRNA suppression and oncogene derepression: LIN28B
- De novo fatty acid synthesis regulation: LIN28B
- TGF-β pathway activation through RNA binding: LIN28B

**Cellular components:**
- RNA binding protein complexes: RBFOX1, SRRM4, LIN28B

**Reference notes:**
- LIN28B is overexpressed in DMG and suppresses let-7 microRNAs, promoting oncogene expression
- LIN28 proteins enhance de novo fatty acid synthesis through post-transcriptional regulation of SREBP-1
- LIN28B promotes TGF-β signaling and cell migration through feedback loop involving TGFBI
- RBFOX1 regulates alternative splicing of multiple genes important for cellular structure and function
- Rbfox1 complex controls splicing through RNA motif binding

### Transcriptional Control of Neural Differentiation
Transcription factors that specify neuronal identity and regulate differentiation versus proliferation decisions. This program includes EBF family proteins (EBF1, EBF2), MYT1L (myelin transcription factor 1-like), CUX2 (cut-like homeobox 2), RUNX1T1 (runt-related transcription factor), and POU6F2 (POU class 6 homeobox). In GBM, dysregulation or loss of these differentiation-promoting transcription factors maintains stemness and proliferative capacity while blocking maturation.

**Predicted impacts:**
- Resistance to terminal differentiation and maturation
- Maintenance of stem cell-like transcriptional signatures
- Continued expression of proliferation-promoting genes
- Loss of normal developmental growth arrest signals
- Dysregulation of glial vs. neuronal cell fate decisions

**Supporting genes:** EBF1, EBF2, MYT1L, CUX2, RUNX1T1, POU6F2

**References:** [15], [25]

**Biological processes:**
- EBF-mediated neuronal differentiation: EBF1, EBF2
- MYT1L-directed neuronal maturation: MYT1L
- Fibroblast-to-neuron reprogramming: MYT1L, EBF1, EBF2
- Transcriptional repression of proliferation programs: MYT1L, EBF1, EBF2

**Cellular components:**
- Transcription factor complexes at promoters: EBF1, EBF2, MYT1L, CUX2, RUNX1T1, POU6F2

**Reference notes:**
- MYT1L is critical for neuronal differentiation and maturation; its loss impairs neuronal development
- EBF proteins drive neuronal differentiation and regulate expression of multiple gene classes

### Glioma Stem Cell Maintenance and Stemness
Programs supporting cancer stem cell (CSC) properties including self-renewal, multipotency, and therapy resistance. This program involves LIN28B-mediated repression of let-7 miRNAs, altered metabolism (MTAP, PIP5K1B), and signaling from growth factor receptors (FGFR2, KIT, GFRA1). GBM stem cells exhibit increased invasive potential and resistance to radiotherapy and chemotherapy, and are thought to be key drivers of tumor recurrence and progression.

**Predicted impacts:**
- Self-renewal and multipotency despite differentiation cues
- Increased tumor-initiating capacity
- Enhanced resistance to chemotherapy and radiotherapy
- Promotion of tumor recurrence and progression
- Heterogeneous tumor composition with multiple cell states

**Supporting genes:** LIN28B, FGFR2, KIT, GFRA1, EBF1, EBF2, MYT1L, COL6A3, ADAMTS3, POSTN, CDH9, CDH18, TENM2, MTAP, PIP5K1B

**References:** [19], [26], [51]

**Biological processes:**
- Let-7-independent stemness maintenance: LIN28B
- Glioma stem cell marker expression: EBF1, EBF2, MYT1L
- Growth factor-driven self-renewal signaling: FGFR2, KIT, GFRA1
- Enhanced invasion and migration capacity: COL6A3, ADAMTS3, POSTN, CDH9, CDH18, TENM2

**Reference notes:**
- GSCs are promising therapeutic targets with similarity to neural stem cells and elevated invasive potential
- FGFR1 is preferentially expressed on GSCs and regulates stem cell transcription factors
- LIN28B overexpression promotes stem-like properties in DMG

### Spatial Gene Expression Heterogeneity
Genes supporting distinct gene expression programs in different tumor microenvironments—tumor core vs. infiltrated brain tissue. This program includes genes upregulated in proneural vs. mesenchymal cores (EBF1, EBF2, CDH genes), genes associated with hypoxic/necrotic regions (HIF-pathway related), and genes enriched in infiltrating cells (AC/OPC/NPC-like state markers). In GBM, spatial heterogeneity reflects both genomic alterations and microenvironmental influences that shape tumor cell behavior.

**Predicted impacts:**
- Distinct proliferation and migration strategies in different microenvironments
- Phenotypic plasticity responding to hypoxia and nutrient availability
- Differential therapy response across tumor regions
- Regional heterogeneity in immune infiltration and inflammatory responses
- Spatial segregation of proneural and mesenchymal phenotypes

**Supporting genes:** COL6A3, TGFBI, POSTN, ADAMTS3, CDH9, CDH18, CDH4, EBF1, EBF2, MYT1L, EFNA5, SEMA3C

**References:** [3], [6], [9]

**Biological processes:**
- Mesenchymal state gene expression: COL6A3, TGFBI, POSTN, ADAMTS3, CDH9, CDH18
- Proneural and oligodendrocytic-like state maintenance: EBF1, EBF2, MYT1L
- Hypoxia-induced gene expression: POSTN, TGFBI, CDH9, ADAMTS3
- Notch and glial differentiation signaling: CDH9, CDH18, CDH4, EFNA5, SEMA3C

**Reference notes:**
- Spatial transcriptomics reveals distinct gene expression in tumor core vs. infiltrated tissue with shifts in malignant cell composition
- Hypoxic conditions in GBM activate HIF signaling and alter cell survival and metabolic programs
- COL6A3 enrichment in mesenchymal GBM and MVP regions correlates with aggression

### Metabolic Reprogramming and Lipid Synthesis
Genes supporting altered metabolic states in GBM including enhanced glycolysis, de novo lipid synthesis, and alternative nutrient utilization. LIN28B drives fatty acid synthesis through SREBP-1 pathway; MTAP and associated genes support purine metabolism; metabolic enzymes support rapid biomass accumulation. In GBM, metabolic reprogramming enables rapid proliferation and supports therapy resistance through ER stress evasion and lipid-dependent membrane expansion.

**Predicted impacts:**
- Enhanced de novo lipid synthesis supporting rapid membrane expansion
- Increased biomass production enabling rapid proliferation
- Altered cellular stress responses and ER homeostasis
- Metabolic flexibility supporting survival under nutrient restriction
- Enhanced therapy resistance through metabolic adaptation

**Supporting genes:** LIN28B, MTAP, PIP5K1B, SLC38A11

**References:** [54], [57], [6]

**Biological processes:**
- De novo fatty acid and lipid synthesis: LIN28B, MTAP, PIP5K1B
- ER stress response and lipid homeostasis: LIN28B
- Glucose and nutrient uptake: SLC38A11

**Cellular components:**
- Lipid droplets and ER membranes: LIN28B, MTAP

**Reference notes:**
- Lin28 proteins enhance de novo fatty acid synthesis through SREBP-1 pathway
- LIN28B promotes TGF-β signaling affecting metabolic processes
- GBM cells exhibit metabolic reprogramming with increased nutrient uptake

## References
- [11] Notes: Classic cadherins show restricted expression patterns in neural tissues during development
- [14] Notes: RBFOX1 regulates alternative splicing of multiple genes important for cellular structure and function
- [15] Notes: MYT1L is critical for neuronal differentiation and maturation; its loss impairs neuronal development
- [17] Notes: Rbfox1 complex controls splicing through RNA motif binding
- [19] Notes: RTK signaling is among the most frequent molecular alterations in GBM | GSCs are promising therapeutic targets with similarity to neural stem cells and elevated invasive potential
- [22] Notes: PI3K/AKT and Ras/MAPK pathways are major drivers of GBM progression
- [25] Notes: EBF proteins drive neuronal differentiation and regulate expression of multiple gene classes
- [26] Notes: FGFR1 is a key regulator of tumor growth, invasion, and cancer stemness in GBM | FGFR1 is preferentially expressed on GSCs and regulates stem cell transcription factors
- [27] Notes: CAMs regulate axon growth, fasciculation, and synaptic specificity through trans-interactions
- [29] Notes: FGFR dysregulation in glioma and therapeutic targeting opportunities
- [3] Notes: Spatial transcriptomics reveals distinct gene expression in tumor core vs. infiltrated tissue with shifts in malignant cell composition
- [30] Notes: Latrophilin-teneurin complexes regulate neuronal circuit assembly
- [31] Notes: Semaphorins and their receptors mediate axon guidance, cell migration, and growth cone collapse
- [32] Notes: UNC5-netrin interactions mediate cell migration and axon guidance through heparin-binding mechanisms
- [33] Notes: CNTNAP4 is involved in dopaminergic neuron function and synaptic transmission
- [34] Notes: Semaphorins have multiple roles in axon guidance, cell migration, and cell death with temporal regulation
- [35] Notes: Netrin and UNC5 signaling regulates migration of specific neuronal populations during development
- [37] Notes: GDNF-GFRα1 complexes support synaptic cell adhesion
- [4] Notes: TRPM3 loss of expression is a poor prognosis marker in GBM; dysregulation closely related to glioma occurrence and development
- [43] Notes: Synaptotagmin is critical calcium sensor for neurotransmitter release; its expression affects exocytosis
- [44] Notes: TMEM16 proteins link Ca2+ signals with cellular electrical activity and are dysregulated in cancer
- [47] Notes: Anoctamins (TMEM16) in brain cancer: calcium-activated chloride channels in EGFR signaling and glioma
- [51] Notes: LIN28B is overexpressed in DMG and suppresses let-7 microRNAs, promoting oncogene expression | LIN28B overexpression promotes stem-like properties in DMG
- [54] Notes: LIN28 proteins enhance de novo fatty acid synthesis through post-transcriptional regulation of SREBP-1 | Lin28 proteins enhance de novo fatty acid synthesis through SREBP-1 pathway
- [55] Notes: ADAM/ADAMTS proteases regulate tissue remodeling through ECM degradation and cell migration
- [57] Notes: LIN28B/TGF-β feedback loop promotes TGFBI expression and cancer cell migration | LIN28B promotes TGF-β signaling and cell migration through feedback loop involving TGFBI | LIN28B promotes TGF-β signaling affecting metabolic processes
- [59] Notes: SMOC proteins regulate cell adhesion, tissue fibrosis, and calcification relevant to tumor microenvironment
- [6] Notes: Hypoxic conditions in GBM activate HIF signaling and alter cell survival and metabolic programs | GBM cells exhibit metabolic reprogramming with increased nutrient uptake
- [60] Notes: TGFBI is a prognostic marker affecting cancer cell migration and invasion
- [8] Notes: Cadherins and nectins cooperate in adhesion and regulate neuronal migration and differentiation
- [9] Notes: Core evidence: GBM cells secrete extensive ECM, particularly collagen VI, which facilitates invasion and is associated with bevacizumab resistance | COL6A3 enrichment in mesenchymal GBM and MVP regions correlates with aggression
